Skip to main content
SpringerLink
Log in

L’érythropoïétine humaine recombinante (rEpo) n’a d’effet ni sur la croissance tumorale, ni sur l’angiogénèse

  • ONCOLOGIE
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Centre Antoine Lacassagne, 33, avenue de Valombrose, 06189, Nice cedex 2

    M. Schneider

Authors
  1. M. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Analyse de: M E Hardee, J P Kirkpatrick, S Shan et al (2005) Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis. British Journal of Cancer 93, 1350-5

About this article

Cite this article

Schneider, M. L’érythropoïétine humaine recombinante (rEpo) n’a d’effet ni sur la croissance tumorale, ni sur l’angiogénèse. Oncologie 8, 180–181 (2006). https://doi.org/10.1007/s10269-006-0340-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-006-0340-3

Search

Navigation